Ubrogepant
The acute migraine medication that starts with "U" is ubrogepant, a CGRP receptor antagonist (gepant) approved for treating acute migraine attacks in adults.
What is Ubrogepant?
Ubrogepant is a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist that blocks CGRP—a protein released during migraine attacks—from binding to its receptors 1, 2. It is available in 50 mg and 100 mg oral formulations.
When to Use Ubrogepant
According to the most recent American College of Physicians clinical guideline from 2025, ubrogepant should be considered for treating moderate to severe acute episodic migraine in nonpregnant outpatient adults who do not tolerate or have inadequate response to combination therapy of a triptan plus an NSAID or acetaminophen 3.
Treatment Algorithm Position:
- First-line: NSAID or acetaminophen for mild migraine
- Second-line: Triptan + NSAID (or triptan + acetaminophen if NSAIDs contraindicated)
- Third-line: Ubrogepant (or other gepants like rimegepant/zavegepant) for patients who fail or cannot tolerate triptan combinations 3
Clinical Efficacy
Ubrogepant demonstrated superiority over placebo in large phase 3 trials, though the therapeutic gain appears modest 2. A case report showed dramatic improvement in a treatment-resistant patient: headache duration decreased from 36-60 hours to less than 12 hours, severity dropped from 7.5/10 to 3/10, and monthly headache days reduced from 10-12 to 5 days 1.
Key Advantages
- Favorable safety profile: Does not significantly affect liver function and lacks serious adverse events associated with other acute migraine medications 2
- No vasoconstriction: Unlike triptans, ubrogepant does not cause vasoconstriction, making it potentially safer for patients with cardiovascular concerns 4
- Well-tolerated long-term: Non-serious adverse events similar to placebo in extended studies 2
Important Caveats
- Not for pregnant patients: The 2025 guideline specifically restricts use to nonpregnant adults 3
- Cost considerations: Prescribe less costly recommended medications when appropriate; ubrogepant is typically more expensive than generic triptans 3
- Medication overuse headache risk: Like all acute migraine treatments, limit use to avoid medication overuse headache (threshold varies by medication class) 3